The management of treatment resistance in depressed patients with substance use disorders (Q41127953)

27 September 2017

1 reference

title

The management of treatment resistance in depressed patients with substance use disorders (English)

1 reference

27 September 2017

1

Nunes EV

1 reference

27 September 2017

Deliyannides D

2

1 reference

PubMed ID

8827192

27 September 2017

Donovan S

series ordinal

3

1 reference

PubMed ID

8827192

27 September 2017

McGrath PJ

series ordinal

4

1 reference

27 September 2017

1 June 1996

1 reference

Psychiatric Clinics of North America

27 September 2017

1 reference

27 September 2017

19

1 reference

27 September 2017

2

1 reference

27 September 2017

311-327

1 reference

Desipramine treatment of cocaine dependence in methadone-maintained patients

27 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Abuse of monoamine oxidase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

A double-blind placebo controlled study of desipramine in the treatment of ADD: III. Lack of impact of comorbidity and family history factors on clinical response

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Evidence of familial association between attention deficit disorder and major affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Psychiatric comorbidity among referred juveniles with major depression: fact or artifact?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Gender differences in a sample of adults with attention deficit hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Methadone Maintenance and Amitriptyline

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

One-year follow-up status of treatment-seeking cocaine abusers. Psychopathology and dependence severity as predictors of outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Psychotherapy and pharmacotherapy for ambulatory cocaine abusers.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Tricyclic antidepressants in the treatment of depression associated with alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Abuse of amitriptyline

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Effects of combined fluoxetine and counseling in the outpatient treatment of cocaine abusers.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Phoenix House. Changes in psychopathological signs of resident drug addicts.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Lithium Treatment of Aggressive Behavior in Depressed, Drug-Dependent Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Desipramine facilitation of initial cocaine abstinence.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Bromocriptine-desipramine protocol in treatment of cocaine addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Cigarette smoking: implications for psychiatric illness

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Social networks and methadone treatment outcome: the costs and benefits of social ties.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: two placebo-controlled double-blind trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Posttreatment depression in an alcohol and drug abuse population

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Should caffeine abuse, dependence, or withdrawal be added to DSM-IV and ICD-10?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Anxiety and depressive disorders in attention deficit disorder with hyperactivity: new findings

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Imipramine as Treatment for Depression in Addicts

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

A 2.5-year follow-up of depression, life crises, and treatment effects on abstinence among opioid addicts

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Buspirone Treatment of Anxious Alcoholics

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Treatment response in psychiatrically impaired drug abusers.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Suicidality, depression, and substance abuse in adolescence.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Alcoholism in antisocial and nonantisocial men with unipolar major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Long-term predictors of outcome in abstinent alcoholic men.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Changes in Cocaine Use After Entry to Methadone Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Imipramine treatment of alcoholics with primary depression: A placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Multiple Risk Factors Predict Suicide in Alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Factors Affecting Outcome of Depressive Symptoms in Alcoholics

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Imipramine treatment of methadone maintenance patients with affective disorder and illicit drug use

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Evaluation and treatment of mood and anxiety disorders in opioid-dependent patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Antidepressant treatment in methadone maintenance patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Imipramine treatment of alcoholism with comorbid depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Imipramine treatment of cocaine abuse: possible boundaries of efficacy.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Naltrexone and coping skills therapy for alcohol dependence. A controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Serious adverse effects of combining fluoxetine and tricyclic antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Long-term changes in current psychiatric diagnoses of treated opiate addicts.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Psychopathology as a predictor of treatment outcome in alcoholics.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Prognostic significance of psychopathology in treated opiate addicts. A 2.5-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Psychiatric diagnoses of treatment-seeking cocaine abusers.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Diagnosis and symptoms of depression in opiate addicts. Course and relationship to treatment outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Should protracted withdrawal from drugs be included in DSM-IV?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Alcoholic patients with secondary depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Genetic and clinical implications of alcoholism and affective disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Correlates of self-reported and clinically assessed depression in outpatient alcoholics

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Caffeine dependence syndrome. Evidence from case histories and experimental evaluations

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Naltrexone in the treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Comparison of Amantadine and Desipramine Combined with Psychotherapy for Treatment of Cocaine Dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Clinical depression among narcotic addicts maintained on methadone in the community

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

What Happens to Heroin Addicts? A Follow-up Study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

Depression and anxiety in heroin addicts: a placebo-controlled study of doxepin in combination with methadone

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

The use of antidepressants with methadone in depressed maintenance patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970290-2

7 January 2021

10.1016/S0193-953X(05)70290-2

Identifiers

DOI

1 reference

27 September 2017

1 reference

PubMed ID

8827192